Date Closed

January 14, 2009

Lead Office

Montréal

On January 15, 2009, Alpine Biomed Corporation, a global leader in specialty diagnostic devices, announced that it has acquired Stellate Systems Inc. The acquisition is the second that Alpine Biomed has completed since Water Street Healthcare Partners, a leading private equity firm focused exclusively on health care, invested in the company in 2007.

The combination significantly increases the size of Alpine Biomed's neurology business and gives the company a strong foothold in the rapidly growing sleep diagnostics market. Estimated to affect as many as 40 million Americans, sleep disorders have become one of the nation's top health conditions requiring diagnosis and treatment. Alpine Biomed will also offer products and software that detect and monitor a range of conditions including epilepsy and muscular disorders such as carpal tunnel syndrome. Additionally, Stellate's strength in research and development will enhance Alpine's product development capabilities.

Stellate, headquartered in Montréal, Québec, specializes in the development and production of advanced neurodiagnostic systems.

Alpine Biomed, headquartered in Fountain Valley, California, engages in designing, manufacturing, and distributing diagnostic equipment and accessories used in gastroenterology and neurology.

McCarthy Tétrault LLP represented Alpine Biomed, as acquirer, with a team that was led by Ian Palm.